… In this trial (NCT04746183) we evaluated the safety and optimal dose of … safety and tolerability
of multiple ascending doses of molnupiravir in participants with PCR-confirmed SARS-CoV…

… safety of a SARS-CoV-2 inactivated vaccine (CoronaVac). … to evaluate the optimal dose,
immunogenicity and safety of the … 2 injections of the trial vaccine at a dose of 3 μg/0.5 mL or 6 μg …

… Due to the impossibility of not using the drug recommended at the national … dosage of CQ
(12 g total dose over 10 days) in COVID-19 should not be recommended because of safety …

… being developed against SARS-CoV-2. We present interim safety and immunogenicity results
of the … candidate vaccine will focus on identifying the optimal antigen formulation and dose. …

… When used in the treatment of acute worsening of chronic pancreatitis or postoperative
reflux oesophagitis, the recommended dosage is 300-600 mg/day in three dosages of 100-200 …

… of mRNA and/or ChAdOx1 vaccines gave excellent protection against … doses improved VE
and may be optimal in most circumstances. Findings indicate prolonged two-dose protection …

… of immune protection from symptomatic SARS-CoV-2 infection … ) received both doses of the
vaccine at the recommended 1-… the first dose and so did not receive a second dose. Baseline …

… inhibitors (TKIs) versus SARS-CoV-2 infection in patients … expected problems in terms of
safety, the efficacy data have to be … A real uncertainty exists about the optimal timing, dosing and …

… Focusing on adults with early symptomatic COVID-19, the optimal dose and safety of
molnupiravir were evaluated through a multicenter, multistage, open-label, phase-Ib/IIa randomized …

… To obtain the best experience, we recommend you use a … the safety results of the 25 mg
dose group, as well as the ongoing clinical trial in Uzbekistan, adjustment was made for the dose …